Therefore, abnormal tau phosphorylation may be caused by reduced O-GlcNAcylation and that increasing the O-GlcNAcylation level of tau may inhibit pathological hyperphosphorylation in AD [75, 137]. This evidence concerns the gene MAPT and Alzheimer disease.